Health News
At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
No Shortage of Hepatitis C Treatments
In the last three years, there have been many advances in treating hepatitis C, which can not only offer patients more treatment options but also shorter treatment times.
Smoking: A Habit to Kick for Life
If you need another reason to quit smoking, keep reading. New evidence supports past findings that smokers face a raised risk for many health problems.
Chicken Pox Virus Tied to More Than Just Shingles
Talk of chicken pox often brings up itchy childhood memories, but the virus behind the illness may be tied to other issues that are a bit harder to scratch.
How Sore Throat Without Strep Could Still Be Serious
When a patient has a sore throat but not strep, doctors usually prescribe rest and lots of fluids. However, aching throats may warrant more serious medical attention.
Ebola Tide Subsided, but the Fight's Not Over
The US is set to withdraw nearly all of its troops deployed to fight the Ebola outbreak in West Africa — a sign of the disease's recent slowdown. Officials cautioned, however, that the fight isn't over.
Measles Keeps Moving
As more and more patients are diagnosed, measles is quickly reaching the forefront of the public's health concerns.
Smoking May Be Even Riskier Than Once Thought
Smokers, it’s never too late to quit — and there may now be even more good reasons to do so.
Experimental Rx May Cure Hepatitis C in Six Weeks
Achillion Pharmaceuticals Inc. announced today that its experimental hepatitis C treatment may be able to reverse hepatitis C in as little as six weeks.
Breathe Easy, Parents: Vaccine Not Tied to More STDs
Some parents have raised concerns that vaccinating young girls against HPV, a sexually transmitted illness, might lead to more unsafe sexual activity in these girls. New evidence, however, suggests that's not the case — and the vaccine could prevent serious health problems.
Achillion Achieves 100% SVR12 in Phase 2 Trial
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced updated interim results from the ongoing interferon-free, ribavirin-free, Phase 2 study to evaluate the efficacy, safety, and tolerability of six weeks of 50 mg of ACH-3102 and 400 mg of sofosbuvir, a marketed nucleotide polymerase inhibitor, in treatment-naïve genotype 1 HCV-infected patients.